Natural Compound from Olive Oil Inhibits S100A9 Amyloid Formation and Cytotoxicity: Implications for Preventing Alzheimer’s Disease
暂无分享,去创建一个
M. Bucciantini | M. Stefani | Jonathan Pansieri | Himanshu Chaudhary | V. Smirnovas | L. Morozova-Roche | Ž. Svedružić | M. Leri | Greta Musteikyte | Igor A Iashchyshin | Silvia Gómez Alcalde
[1] R. Antoine,et al. Templating S100A9 amyloids on Aβ fibrillar surfaces revealed by charge detection mass spectrometry, microscopy, kinetic and microfluidic analyses , 2020, bioRxiv.
[2] M. Bucciantini,et al. Healthy Effects of Plant Polyphenols: Molecular Mechanisms , 2020, International journal of molecular sciences.
[3] S. Tomasi,et al. UV-Vis Spectroelectrochemistry of Oleuropein, Tyrosol, and p-Coumaric Acid Individually and in an Equimolar Combination. Differences in LC-ESI-MS2 Profiles of Oxidation Products and Their Neuroprotective Properties , 2019, Biomolecules.
[4] M. Bucciantini,et al. Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol. , 2019, Biochemical pharmacology.
[5] A. Gräslund,et al. Pro-Inflammatory S100A9 Protein Aggregation Promoted by NCAM1 Peptide Constructs. , 2019, ACS chemical biology.
[6] N. Marklund,et al. Proinflammatory and amyloidogenic S100A9 induced by traumatic brain injury in mouse model , 2019, Neuroscience Letters.
[7] M. Bucciantini,et al. Oleuropein aglycone and hydroxytyrosol interfere differently with toxic Aβ1-42 aggregation. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[8] Sunhwan Jo,et al. CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans. , 2018, Journal of chemical theory and computation.
[9] S. Shankar,et al. S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer’s Disease , 2018, Scientific Reports.
[10] I. Horváth,et al. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson’s disease: ex vivo and in vitro studies , 2018, Journal of Neuroinflammation.
[11] M. Bucciantini,et al. Oleuropein aglycone: A polyphenol with different targets against amyloid toxicity. , 2018, Biochimica et biophysica acta. General subjects.
[12] M. Bucciantini,et al. Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates , 2018, Scientific Reports.
[13] D. Raleigh,et al. RAGE binds preamyloid IAPP intermediates and mediates pancreatic &bgr; cell proteotoxicity , 2018, The Journal of clinical investigation.
[14] V. Smirnovas,et al. Finke-Watzky Two-Step Nucleation-Autocatalysis Model of S100A9 Amyloid Formation: Protein Misfolding as "Nucleation" Event. , 2017, ACS chemical neuroscience.
[15] Charles L. Brooks,et al. CHARMM‐GUI ligand reader and modeler for CHARMM force field generation of small molecules , 2017, J. Comput. Chem..
[16] Ž. Svedružić,et al. In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1 , 2017, PloS one.
[17] Yanbo Zhang,et al. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease , 2017, CNS neuroscience & therapeutics.
[18] S. Strittmatter,et al. Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease. , 2017, Biochemical and biophysical research communications.
[19] M. Sperandio,et al. S100A8/A9: From basic science to clinical application. , 2016, Pharmacology & therapeutics.
[20] Hongchun Li,et al. Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: A novel route to drug development against cell proliferation. , 2016, Biochimica et biophysica acta.
[21] S. Strittmatter,et al. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease* , 2016, The Journal of Biological Chemistry.
[22] Seung-Jae Lee,et al. Neuroinflammation in Synucleinopathies , 2016, Brain pathology.
[23] S. Doglia,et al. The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. , 2016, The Journal of nutritional biochemistry.
[24] M. Bucciantini,et al. Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin , 2016, Journal of cellular and molecular medicine.
[25] H. Zetterberg,et al. Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease. , 2016, ACS chemical neuroscience.
[26] M. Stefani,et al. Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight , 2015, Oncotarget.
[27] M. Stefani,et al. Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation , 2014, BioFactors.
[28] C. Bremer,et al. Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity , 2014, Nature Communications.
[29] Xavier Barril,et al. rDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids , 2014, PLoS Comput. Biol..
[30] Franco Quercioli,et al. A molecular imaging analysis of C×43 association with Cdo during skeletal myoblast differentiation , 2014, Photonics West - Biomedical Optics.
[31] Patrick Walsh,et al. The Mechanism of Membrane Disruption by Cytotoxic Amyloid Oligomers Formed by Prion Protein(106–126) Is Dependent on Bilayer Composition* , 2014, The Journal of Biological Chemistry.
[32] S. Shankar,et al. The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade , 2013, Acta Neuropathologica.
[33] M. Stefani,et al. The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology , 2013, PloS one.
[34] L. Formigli,et al. A molecular imaging analysis of Cx43 association with Cdo during skeletal myoblast differentiation , 2013, Journal of biophotonics.
[35] A. Tall,et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. , 2013, Cell metabolism.
[36] Francesco S Pavone,et al. Partitioning and confinement of GM1 ganglioside induced by amyloid aggregates , 2013, FEBS letters.
[37] L. Morozova-Roche,et al. Aggregation of Human S100A8 and S100A9 Amyloidogenic Proteins Perturbs Proteostasis in a Yeast Model , 2013, PloS one.
[38] J. Voorhees,et al. Robust shifts in S100a9 expression with aging: A novel mechanism for chronic inflammation , 2013, Scientific Reports.
[39] Wim F Vranken,et al. ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.
[40] R. Veerhuis,et al. Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease , 2012, Alzheimer's Research & Therapy.
[41] M. Fujita,et al. S100A8/A9 complex as a new biomarker in prediction of mortality in elderly patients with severe heart failure. , 2012, International journal of cardiology.
[42] Francesco Pavone,et al. Toxic effects of amyloid fibrils on cell membranes: the importance of ganglioside GM1 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] M. Bucciantini,et al. Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. , 2011, Current Alzheimer research.
[44] G. Lippens,et al. Oleuropein and derivatives from olives as Tau aggregation inhibitors , 2011, Neurochemistry International.
[45] J. Marsh,et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers , 2010, Molecular Neurodegeneration.
[46] M. Bucciantini,et al. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. , 2010, The Journal of nutritional biochemistry.
[47] V. Perry,et al. Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.
[48] C. Dobson,et al. Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate , 2009, PloS one.
[49] R. Keast,et al. Chemistry and Health of Olive Oil Phenolics , 2008, Critical reviews in food science and nutrition.
[50] A. Gliozzi,et al. Nonspecific Interaction of Prefibrillar Amyloid Aggregates with Glutamatergic Receptors Results in Ca2+ Increase in Primary Neuronal Cells* , 2008, Journal of Biological Chemistry.
[51] T. Vogl,et al. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. , 2006, Biochimica et biophysica acta.
[52] O. Bocharova,et al. Amyloid Fibrils of Mammalian Prion Protein Are Highly Toxic to Cultured Cells and Primary Neurons* , 2006, Journal of Biological Chemistry.
[53] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[54] Ian Parker,et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.
[55] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[56] Fabrizio Chiti,et al. Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity* , 2004, Journal of Biological Chemistry.
[57] B. Sacchetti,et al. Astrocyte modulation of in vitro β‐amyloid neurotoxicity , 2004, Glia.
[58] P. Eilers. A perfect smoother. , 2003, Analytical chemistry.
[59] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[60] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[61] P. Kremsner,et al. Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells , 1998, Acta Neuropathologica.
[62] H. Schluesener,et al. Expression of the S‐100 proteins MRP‐8 and ‐14 in ischemic brain lesions , 1997, Glia.
[63] Z. Wasylewski,et al. Fluorescence-quenching-resolved spectroscopy of proteins. , 1988, European journal of biochemistry.
[64] A. Diaspro,et al. Amyloid and membrane complexity: The toxic interplay revealed by AFM. , 2018, Seminars in cell & developmental biology.
[65] M. Stefani,et al. The Polyphenol Oleuropein Aglycone Modulates the PARP1-SIRT1 Interplay: An In Vitro and In Vivo Study. , 2016, Journal of Alzheimer's disease : JAD.
[66] J. Markowitz,et al. Review of S100A9 biology and its role in cancer. , 2013, Biochimica et biophysica acta.
[67] K. Yanagisawa. [Amyloid hypothesis]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[68] Kwok-Fai So,et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. , 2009, Neurotoxicology.
[69] I. Ferrer,et al. Prion protein expression in senile plaques in Alzheimer's disease , 2000, Acta Neuropathologica.
[70] R. Wetzel,et al. Amyloid, prions, and other protein aggregates , 1999 .
[71] F. Ferrone,et al. Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.
[72] H. Levine. Thioflavine T interaction with amyloid β-sheet structures , 1995 .